(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is announcing the addition of Michael Power as Senior Director, State Affairs and new roles for Tim Dube, Melodie Shrader, Heather Cascone, and Randy Kane. Michael Power joins PCMA with a long list
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today issued 21 policy solutions supported by America’s pharmacy benefit managers (PBMs) aimed at reducing prescription drug costs for patients and health plan sponsors. PBMs administer prescription drug plans for more than 266 million Americans with
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is announcing two new additions to its Regulatory Affairs and Research teams. Debjani Mukherjee joins PCMA as a Senior Director of Regulatory Affairs. Debjani comes to PCMA from the Planned Parenthood Association, where she served
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott joined other organization and company CEOs to sign the CEO Action Pledge supporting more diversity and inclusion within the workplace. The CEO pledge outlines a specific set of actions
(Washington, D.C.) — Pharmaceutical Care Management Association President and CEO JC Scott released the following statement on incoming Health and Human Services Secretary Xavier Becerra. “The Pharmaceutical Care Management Association, representing America’s pharmacy benefit managers (PBMs), congratulates the new Secretary
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the pending confirmations of three officials of the U.S. Department of Health and Human Services (HHS): Chiquita Brooks-LaSure, nominee for Administrator for
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today announced that Katie Payne has been appointed Senior Vice President of Strategic Communications. In her role, Ms. Payne will be responsible for leading PCMA’s communications function and will oversee the
S. 127 Does Nothing to Address Root Cause of High Drug Prices and Would Increase Costs for Patients and Employers (Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on today’s hearing
Named a 2022 Top Lobbyist by The Hill, Lebens Will Lead PCMA’s Federal Lobbying Team (Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is today announcing Lucia Lebens as Senior Vice President of Federal Affairs and Political Strategy at
Pharmacy Benefit Companies Negotiate with Big Drug Companies to Lower Prescription Drug Costs for Patients and Families Last week, the U.S. Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing, “The Need to Make Insulin Affordable for All Americans,”
